Cargando…
Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells
INTRODUCTION: Acquired tamoxifen resistance remains the major obstacle to breast cancer endocrine therapy. β1-integrin was identified as one of the target genes of G protein-coupled estrogen receptor (GPER), a novel estrogen receptor recognized as an initiator of tamoxifen resistance. Here, we inves...
Autores principales: | Yuan, Jie, Liu, Manran, Yang, Li, Tu, Gang, Zhu, Qing, Chen, Maoshan, Cheng, Hong, Luo, Haojun, Fu, Weijie, Li, Zhenhua, Yang, Guanglun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453053/ https://www.ncbi.nlm.nih.gov/pubmed/25990368 http://dx.doi.org/10.1186/s13058-015-0579-y |
Ejemplares similares
-
GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer
por: Mo, Zhiqiang, et al.
Publicado: (2013) -
Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to
Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021) -
Fibronectin expression is upregulated by PI-3K/Akt activation in tamoxifen-resistant breast cancer cells
por: You, Daeun, et al.
Publicado: (2017) -
Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021) -
Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)